ERGO.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 lapkr. 2023 @ 18:29):

Stats
Dzisiejszy wolumen	33 234.00
Średni wolumen	922 955
Kapitalizacja rynkowa	771.71M
EPS	£0 ( 2024-03-18 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	48.14
ATR14	£15.31 (1.14%)

Wolumen Korelacja

Długi: 0.36 (neutral)

Krótki: 0.07 (neutral)

Signal:(66.053) Neutral

Ergomed PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ergomed PLC Korelacja - Waluta/Towar

0.86
( strong )

0.55
( weak )

0.52
( weak )

0.58
( weak )

-0.75
( moderate negative )

Ergomed PLC Finanse

Annual	2022
Przychody:	£145.26M
Zysk brutto:	£59.15M (40.72 %)
EPS:	£0.300

FY	2022
Przychody:	£145.26M
Zysk brutto:	£59.15M (40.72 %)
EPS:	£0.300

FY	2021
Przychody:	£118.58M
Zysk brutto:	£48.36M (40.78 %)
EPS:	£0.260

FY	2020
Przychody:	£86.39M
Zysk brutto:	£39.65M (45.90 %)
EPS:	£0.200

Financial Reports:

No articles found.

Ergomed PLC

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.